SCHEMBL25751763

SCHEMBL25751763

c1ccc(-c2ccc3c(c2)c2ccccc2n3-c2cccc(-c3nc4cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)ccc4o3)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPSE Q9Y251 11/20 0.49
▸ SMN1; SMN2 Q16637 5/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ TP53 P04637 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ CASP3 P42574 2/20 0.39
▸ SENP7 Q9BQF6 2/20 0.39
▸ SENP6 Q9GZR1 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ UTRN P46939 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25459466 0.98 HPSE (0.47) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL25459477 0.95 SMN1; SMN2 (0.47) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL25459469 0.95 HPSE (0.47) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL25459403 0.95 HPSE (0.48) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL25751813 0.94 HPSE (0.44) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL27049522 0.94 HPSE (0.46) HPSESMN1; SMN2KDM4EHPGDALDH1A1
SCHEMBL23079866 0.94 HPSE (0.50) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL23118822 0.93 KDM4E (0.48) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL23079777 0.93 HPSE (0.45) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL25459473 0.93 HPSE (0.51) HPSESMN1; SMN2KDM4EKMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, PPOX HPSE 3938/4885SMN1; SMN2 4240/4885KDM4E 2446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback